Related Experiment Video
Updated: May 10, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Factors Associated with Combination Therapy Involving Traditional Korean Medicine in Pediatric Allergic Rhinitis
Mi Ju Son1, Kyung-Min Shin1, Changsop Yang1
1KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
Insights
This study found that school-aged children, winter season, and comorbidities like atopic dermatitis predict combination therapy use in pediatric allergic rhinitis (AR) patients. Integrating traditional Korean medicine (KM) may benefit these children.
Area of Science:
- Pediatric Allergy and Immunology
- Integrative Medicine
- Health Services Research
Background:
- Allergic rhinitis (AR) significantly impacts children's quality of life and healthcare systems.
- Prevalence of pediatric AR is increasing globally.
- Combination therapy with traditional Korean medicine (KM) and conventional medicine is utilized for pediatric AR.
Purpose of the Study:
- To investigate factors associated with KM combination therapy use in pediatric AR patients.
- To analyze large-scale health insurance data for insights into treatment patterns.
- To identify predictors of combined therapy utilization.
Main Methods:
- Analysis of health insurance data from 696,182 pediatric AR patients (2018-2021).
- Multivariate logistic regression to identify factors influencing KM therapy utilization.
- Comparison of treatment duration and healthcare costs between therapy groups.
Main Results:
- 61,745 pediatric AR patients received KM combination therapy.
- Predictors of KM combination therapy included school-age, winter season, and comorbidities (e.g., atopic dermatitis).
- KM combination therapy was associated with longer treatment durations and higher costs; COVID-19 pandemic saw a decline in KM use.
Conclusions:
- Integrating KM into pediatric AR treatment may offer benefits, particularly for children with comorbidities or during winter.
- Findings can inform targeted healthcare policies for optimizing pediatric AR management.
- Further research into the efficacy and cost-effectiveness of KM combination therapy is warranted.
Abstract:
Background/Objectives: Allergic rhinitis (AR) significantly affects patients' quality of life and poses a substantial burden on healthcare systems worldwide, with its prevalence rising among pediatric populations. This study aimed to investigate the factors associated with the use of combination therapy involving traditional Korean medicine (KM) and conventional medicine in pediatric AR patients using large-scale health insurance data from South Korea. Methods: Data from 696,182 pediatric patients diagnosed with AR between 2018 and 2021 were analyzed. Multivariate logistic regression was employed to identify factors influencing KM therapy utilization. Results: Among these, 61,745 patients received KM combination therapy. The key predictors of KM combination therapy utilization included school-age children, the winter season, and comorbidities such as rhinitis and atopic dermatitis. Patients receiving KM combination therapy had longer treatment durations and incurred higher healthcare costs compared to those on conventional therapy alone. Additionally, seasonal variations and demographic factors, including a decline in KM use during the Coronavirus Disease 2019 (COVID-19) pandemic, were observed. Conclusions: The findings suggest that integrating KM into pediatric AR treatment may offer potential benefits, especially for children with comorbidities or during the winter months. These insights could guide the development of targeted healthcare policies and strategies to optimize treatment outcomes for pediatric AR patients.
More Related Videos
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
06:08Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Related Concept Videos
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Allergic Drug Reactions
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: